You can download all the course presentations and materials from the following link.

HIV & AIDS treatment in practice (HATIP) is a regular email newsletter for healthcare workers and community-based organisations on HIV treatment in resource-limited settings.

Roadmap of HIV/TB sessions, booths and networking zones.

A new report and supplement from UNAIDS shows that as international funding flattens, more countries are increasing their own share of investments for HIV and that a record 8 million people are now receiving antiretroviral therapy.

WASHINGTON, D.C., July 18, 2012— Donor nation funding in 2011 for HIV in low- and middle-income countries returned to prior levels after a drop in 2010, but has been roughly flat since the recession hit world economies in 2008, according to an annual funding analysis from the Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS).

At least half a million children become ill with tuberculosis (TB) and up to 70 000 children die of it every year. The World Health Organization has estimated that around 10% of global TB caseload occurs in children (0-14 years). However, there are reports that children account for up to 40% of all cases being treated for TB. Children are also susceptible to the dual epidemic of TB--HIV. Most children will catch tuberculosis from a family member and if they are living with HIV they are even more in danger of developing more severe forms of tuberculosis with higher mortality rates. HIV-infected children are at 20 times greater risk of TB disease than HIV-negative children and at much higher risk of TB-related deaths. Paediatric TB has until recently not been a main priority of global TB control efforts for various reasons.

The Roadmap offers a set of practical and African-owned solutions to enhance sustainable responses to AIDS, TB and malaria. 

At least a hundred protesters arrived at South Africa's parliament on 11 July to demonstrate their disapproval of the ongoing court case by Swiss pharmaceutical company Novartis against the Indian government over its patent laws. As the case draws to a close, health organizations say a win for the pharmaceutical company will be a loss to the developing world, which sources the bulk of its generic medicines from India.

The strategy provides a clear definition of CDC's role in global health and will enable the agency to respond effectively to the evolving environment.